ARCA Biopharma Executives
ARCA Biopharma employs about 3 people. The company is managed by 3 executives with a total tenure of roughly 25 years, averaging almost 8.0 years of service per executive, having 1.0 employees per reported executive. Analysis of ARCA Biopharma's management performance can provide insight into the firm performance.
| Christopher Ozeroff SVP Sr. VP, General Counsel and Secretary |
| Thomas Keuer Executive Chief Officer |
ARCA |
ARCA Biopharma Management Team Effectiveness
The company has return on total asset (ROA) of (0.1435) % which means that it has lost $0.1435 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2005) %, meaning that it created substantial loss on money invested by shareholders. ARCA Biopharma's management efficiency ratios could be used to measure how well ARCA Biopharma manages its routine affairs as well as how well it operates its assets and liabilities.ARCA Biopharma Workforce Comparison
ARCA Biopharma is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 861. ARCA Biopharma adds roughly 3.0 in number of employees claiming only tiny portion of equities under Health Care industry.
ARCA Biopharma Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ARCA Biopharma insiders, such as employees or executives, is commonly permitted as long as it does not rely on ARCA Biopharma's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, ARCA Biopharma insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
ARCA Biopharma Notable Stakeholders
An ARCA Biopharma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as ARCA Biopharma often face trade-offs trying to please all of them. ARCA Biopharma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting ARCA Biopharma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Christopher Ozeroff | Sr. VP, General Counsel and Secretary | Profile | |
| Thomas Keuer | Chief Officer | Profile | |
| Jeffrey CPA | Chief Officer | Profile |
About ARCA Biopharma Management Performance
The success or failure of an entity such as ARCA Biopharma often depends on how effective the management is. ARCA Biopharma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of ARCA management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the ARCA management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. The company was incorporated in 2004 and is headquartered in Westminster, Colorado. Arca Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 17 people.
ARCA Biopharma Workforce Analysis
Traditionally, organizations such as ARCA Biopharma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare ARCA Biopharma within its industry.ARCA Biopharma Manpower Efficiency
Return on ARCA Biopharma Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 1.8M | |
| Net Loss Per Executive | 1.8M | |
| Working Capital Per Employee | 12.3M | |
| Working Capital Per Executive | 12.3M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in ARCA Stock
If you are still planning to invest in ARCA Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ARCA Biopharma's history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |